Stocks of Supreme Pharmaceuticals, Inc. (OTCMKTS:SPRWF) Advance Upon News of Incentive Stock Options

Supreme Pharmaceuticals, Inc. (OTCMKTS:SPRWF) announces that they have issued 130,000 stock options to a consultant of the Company.

TORONTO, ONTARIO–(Marketwired – Sep 14, 2016) – Supreme Pharmaceuticals Inc. (the “Company” or “Supreme”) (CSE:SL)(OTC PINK:SPRWF) has issued 130,000 stock options (each an “Option”) to a consultant of the Company. Each Option has an exercise price of $0.77 and is exercisable at any time prior to September 14th, 2021, subject to the terms and conditions of the Company’s Employee Stock Option Plan.

About Supreme

Supreme is a Canadian publicly traded company committed to becoming a leading supplier of affordable medical cannabis through its wholly-owned subsidiary 7 ACRES (formerly AMMCan). 7ACRES is a federally licensed producer of medical cannabis pursuant to the ACMPR operating a 342,000 sq. ft. Hybrid Greenhouse facility. The Hybrid Greenhouse combines the best technology of indoor production with the efficiencies and sustainability of a greenhouse, in a single large-format production footprint. Please visit and for more information.



Potential investors in Supreme Pharmaceuticals, Inc. (OTCMKTS:SPRWF) should be looking at the current and historical short data in order to get a glimpse of where the market believes the stock might be headed.  According to the most recent information, there are 4000 total short interest.  Given the stock’s average daily volume of 191973, this results in N/A days to cover.  In looking at the total shares short in respect to the total outstanding share total of 108820000, yields a 0.00004% of total shares that are short.  Compared to last month, this is a -89.74 change in total short interest.

When investors engage in short selling or “shorting a stock”, they actually borrow shares from an existing owner, sell the borrowed shares at market price, and take the cash.  The short sellers then promise to replace the stock in the future and makes dividend payments out of their own pockets to cover the dividend income that is no longer exists on the original, now borrowed and sold, shares.

They hope that the stock price will fall or that the company will fail and go bankrupt, leading the equity holders to ruin.  The short sellers will then buy the stock back at a much lower price and replace the borrowed shares, pocketing the difference.

Shorting a stock can be very risky if the price doesn’t decline like planned and, in fact, increases.  It’s important for any investor to understand the dangers and potentially catastrophic financial losses of short selling.

Are Supreme Pharmaceuticals, Inc. (OTCMKTS:SPRWF) Shares Ready to Explode?  Sign up to our Newsletter to be the First to Know

Sign up to get our Free Penny Stock Picks Before the Street!

Supreme Pharmaceuticals, Inc. (OTCMKTS:SPRWF) shares closed the most recent session at $0.687, moving from the previous open of $0.07.  This is compared to the stock’s 52-week high of 0.69 and 52-week low of 0.1.  Is now the right time to take stake in the 36160000 market cap company?

Sign Up to Receive Breaking Alerts on Stocks That Are Primed to Make a Run in the Bar Below.

Sign up to get our Free Penny Stock Picks Before the Street!

Disclaimer: The views, opinions, and information expressed in this article are those of the authors and do not necessarily reflect the official policy or position of any company stakeholders, financial professionals, or analysts. Examples of analysis performed within this article are only examples. They should not be utilized to make stock portfolio or financial decisions as they are based only on limited and open source information. Assumptions made within the analysis are not reflective of the position of any analysts or financial professionals.

Related posts

Leave a Comment